Viewing Study NCT00227032


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2025-12-25 @ 7:10 PM
Study NCT ID: NCT00227032
Status: TERMINATED
Last Update Posted: 2012-03-06
First Post: 2005-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module